NO20065923L - Doseringsform for avlevering av multiple legemiddelformer - Google Patents

Doseringsform for avlevering av multiple legemiddelformer

Info

Publication number
NO20065923L
NO20065923L NO20065923A NO20065923A NO20065923L NO 20065923 L NO20065923 L NO 20065923L NO 20065923 A NO20065923 A NO 20065923A NO 20065923 A NO20065923 A NO 20065923A NO 20065923 L NO20065923 L NO 20065923L
Authority
NO
Norway
Prior art keywords
pharmaceutically acceptable
acceptable salt
delivery
dosage form
multiple drug
Prior art date
Application number
NO20065923A
Other languages
English (en)
Norwegian (no)
Inventor
David Edgren
Bih-Hsiung Hsu
Shu Li
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20065923L publication Critical patent/NO20065923L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20065923A 2004-05-21 2006-12-20 Doseringsform for avlevering av multiple legemiddelformer NO20065923L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57331204P 2004-05-21 2004-05-21
PCT/US2005/017678 WO2005112896A2 (en) 2004-05-21 2005-05-20 Dosage form for delivery of multiple drug forms

Publications (1)

Publication Number Publication Date
NO20065923L true NO20065923L (no) 2007-02-13

Family

ID=35159875

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065923A NO20065923L (no) 2004-05-21 2006-12-20 Doseringsform for avlevering av multiple legemiddelformer

Country Status (13)

Country Link
US (1) US20050260264A1 (zh)
EP (1) EP1750678A2 (zh)
JP (1) JP2008506788A (zh)
KR (1) KR20070013316A (zh)
CN (1) CN1960709A (zh)
AU (1) AU2005244966A1 (zh)
BR (1) BRPI0510034A (zh)
CA (1) CA2565253A1 (zh)
IL (1) IL179456A0 (zh)
MX (1) MXPA06013397A (zh)
NO (1) NO20065923L (zh)
WO (1) WO2005112896A2 (zh)
ZA (1) ZA200610770B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003299659A1 (en) 2002-12-13 2004-07-09 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
ES2708552T3 (es) 2002-12-20 2019-04-10 Niconovum Ab Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
US20050287214A1 (en) * 2004-06-28 2005-12-29 Ayer Atul D Squeeze controlled oral dosage form
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
US8637080B2 (en) * 2007-06-28 2014-01-28 Osmotica Kereskedelmi és Szolgáltató, KFT Rupturing controlled release device comprising a subcoat
JP2011506318A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 経口医薬製剤
JP2011506342A (ja) 2007-12-06 2011-03-03 ペイン セラピューティクス インコーポレイテッド 微粉化オピオイド組成物、製剤および剤形、ならびにそれらの製造方法
WO2010031552A1 (en) * 2008-09-17 2010-03-25 Niconovum Ab Process for preparing snuff composition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US20120128730A1 (en) * 2010-11-23 2012-05-24 Nipun Davar Compositions and methods for once-daily treatment of obsessive compulsive disorder with ondansetron
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
US10716761B2 (en) 2017-07-24 2020-07-21 Alcresta Therapeutics, Inc. Ingestible medical delivery devices
WO2023205692A1 (en) * 2022-04-19 2023-10-26 Intrepid Brands, LLC Liquid formulations for oral flavored product

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
NZ537543A (en) * 2002-07-29 2007-08-31 Alza Corp Formulations and high dose osmotic dosage forms for controlled delivery of topiramate

Also Published As

Publication number Publication date
KR20070013316A (ko) 2007-01-30
JP2008506788A (ja) 2008-03-06
IL179456A0 (en) 2007-05-15
MXPA06013397A (es) 2007-01-23
BRPI0510034A (pt) 2007-10-02
WO2005112896A3 (en) 2006-05-18
ZA200610770B (en) 2008-08-27
US20050260264A1 (en) 2005-11-24
CA2565253A1 (en) 2005-12-01
AU2005244966A1 (en) 2005-12-01
WO2005112896A2 (en) 2005-12-01
EP1750678A2 (en) 2007-02-14
CN1960709A (zh) 2007-05-09

Similar Documents

Publication Publication Date Title
NO20065923L (no) Doseringsform for avlevering av multiple legemiddelformer
PH12015502134A1 (en) Mosapride sustained-release preparation for providing pharmacological and clinical effects with once-a-day administration
NO20090593L (no) Modulatorer av farmakokinetikkegenskaper til terapeutika
DK2114383T3 (da) Små-volumen orale transmukosale doseringsformer indeholdende sufentanil til behandling af smerte
EA201001885A1 (ru) Система контролируемой доставки
RS52831B (en) THIN BUPRENORPHINE TILES FOR DRUG REPLACEMENT THERAPY
HK1111902A1 (en) Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof
JP2007522094A5 (zh)
NO20050835L (no) Varmsmelte TTS for administrasjon av rotigotin
WO2007031887A3 (en) Extended release pharmaceutical composition of metformin and a process for producing it
NO20053224D0 (no) Patient controlled drug administration device.
NO20100250L (no) Farmasoytisk preparat som innbefatter en S1P reseptoragonist og en sukkeralkohol, og framgangsmate til fremstilling derav
WO2007048223A3 (en) A gastric retention drug delivery system
NO20062713L (no) 2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister
NO20063411L (no) Fremgangsmater og doseringsformer for okt opploselighet av legemiddelbestanddeler for kontrollert frigiving
AR030306A1 (es) Derivados de piperazina, un procedimiento para su preparacion, composiciones farmaceuticas, un metodo para su fabricacion y el uso de dichos derivados para la fabricacion de un medicamento
NO20084065L (no) Hurtig frigivelses paracetamol tabletter
EA200701324A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
TW200738228A (en) Neramexane modified release matrix tablet
NO20083151L (no) Fast dispersjon omfattende en aktiv bestanddel med et lavt smeltepunkt, og tablett for oral administrering omfattende samme
WO2009043926A3 (en) Oral fast disintegrating tablets
WO2006040779A3 (en) Controlled release gastric floating matrix formulation containing imatinib
ATE468846T1 (de) Magenresistente pharmazeutische dosierform mit n- (2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d- glutaminsäure (lk-423)
UA102885C2 (ru) Таблетка для орального введения, которая содержит тамсулозин и солифенацин
Naumov et al. Synthesis and QSAR study of novel anti-inflammatory active mesalazine–metronidazole conjugates